Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13

被引:69
作者
Pimanda, JE
Maekawa, A
Wind, T
Paxton, J
Chesterman, CN
Hogg, PJ [1 ]
机构
[1] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia
[3] Mildura Base Hosp, Div Paediat, Mildura, Australia
关键词
D O I
10.1182/blood-2003-04-1346
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe deficiency of the von Willebrand Factor (VWF)-cleaving proteinase, ADAMTS13, is associated with the development of thrombotic thrombocytopenic purpura (TTP). Several mutations spread across the ADAMTS13 gene have been identified in association with a deficiency of VWF-cleaving proteinase activity in patients with congenital TTP. The spread of these dysfunctional mutations and the domain structure of ADAMTS13 are suggestive of a complex interaction between the enzyme and its substrate. We have studied a patient with congenital TTP who is a compound heterozygote for the Thr196Ile mutation in the metal loproteinase domain and a frameshift mutation (4143-4144insA) in the second CUB domain that results in loss of the last 49 amino acids of the protein. The VWF-cleaving proteinase activity of the truncated enzyme was comparable to that of the wild-type enzyme but its secretion from transfected COS-7 cells was about 14% of the wild type.
引用
收藏
页码:627 / 629
页数:3
相关论文
共 25 条
[1]   ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13 [J].
Antoine, G ;
Zimmermann, K ;
Plaimauer, B ;
Grillowitzer, M ;
Studt, JD ;
Lämmle, B ;
Scheiflinger, F .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :821-824
[2]   Structural biology of C1: dissection of a complex molecular machinery [J].
Arlaud, GJ ;
Gaboriaud, C ;
Thielens, NM ;
Rossi, V ;
Bersch, B ;
Hernandez, JF ;
Fontecilla-Camps, JC .
IMMUNOLOGICAL REVIEWS, 2001, 180 :136-145
[3]   Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency [J].
Assink, K ;
Schiphorst, R ;
Allford, S ;
Karpman, D ;
Etzioni, A ;
Brichard, B ;
van de Kar, N ;
Monnens, L ;
van den Heuvel, L .
KIDNEY INTERNATIONAL, 2003, 63 (06) :1995-1999
[4]  
BANNO F, 2003, J THROMB HAEMOST, V1, pA120
[5]  
BERNARDO A, 2003, J THROMB HAEMOST, V1, pA405
[6]   Low resolution structure determination shows procollagen C-proteinase enhancer to be an elongated multidomain glycoprotein [J].
Bernocco, S ;
Steiglitz, BM ;
Svergun, DI ;
Petoukhov, MV ;
Ruggiero, F ;
Ricard-Blum, S ;
Ebel, C ;
Geourjon, C ;
Deléage, G ;
Font, B ;
Eichenberger, D ;
Greenspan, DS ;
Hulmes, DJS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) :7199-7205
[7]   Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura [J].
Furlan, M ;
Robles, R ;
Solenthaler, M ;
Lämmle, B .
BLOOD, 1998, 91 (08) :2839-2846
[8]   Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis [J].
Furlan, M ;
Robles, R ;
Lammle, B .
BLOOD, 1996, 87 (10) :4223-4234
[9]  
Gerritsen HE, 1999, THROMB HAEMOSTASIS, V82, P1386
[10]   Assignment of homology to genome sequences using a library of hidden Markov models that represent all proteins of known structure [J].
Gough, J ;
Karplus, K ;
Hughey, R ;
Chothia, C .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 313 (04) :903-919